Skip to content
Back to TMCI

Treace Medical Concepts, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
12
Purchases
12
Sales
0
Purchase value
$1.24M
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

John T. TreaceDirector · Chief Executive Officer · 10% owner
4
Filed Aug 24, 2026Period of report Aug 20, 20260001193125-26-363737
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 24, 2026
Common StockF3F211,000$4.3392$47.73K7,404,383Direct
PurchaseAug 21, 2026
Common StockF25,000$4.3495$21.75K7,393,383Direct
PurchaseAug 20, 2026
Common StockF1F239,944$4.4356$177.18K7,388,383Direct
Filing footnotes · 5
  1. F1The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3198 to $4.5048 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  2. F2Includes 542,784 restricted stock units.
  3. F3The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3097 to $4.3489 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  4. F4The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
  5. F5The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Open on SEC EDGAR
John T. TreaceDirector · Chief Executive Officer · 10% owner
4/AAmendment
Filed Jun 12, 2026Period of report Jun 10, 20260001193125-26-268606
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJun 11, 2026
Common StockF4F5F39,891$4.0423$39.98K7,348,439Direct
PurchaseJun 10, 2026
Common StockF1F2F314,715$4.024$59.21K7,338,548Direct
Filing footnotes · 7
  1. F1The original Form 4, filed on June 11, 2026, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a purchase that occurred on June 10, 2026 as a total of 29,430 shares purchased when in fact 14,715 shares of the Issuer's common stock were purchased.
  2. F2The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9300 to $4.1000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  3. F3Includes 542,784 restricted stock units.
  4. F4The original Form 4, filed on June 11, 2026, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a purchase that occurred on June 11, 2026 as a total of 22,887 shares purchased when in fact 9,891 shares of the Issuer's common stock were purchased.
  5. F5The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.9600 to $4.1700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  6. F6The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
  7. F7The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Open on SEC EDGAR
John T. TreaceDirector · Chief Executive Officer · 10% owner
4
Filed Jun 1, 2026Period of report Jun 1, 20260001193125-26-251587
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJun 1, 2026
Common StockF1F250,000$3.5583$177.92K7,323,833Direct
Filing footnotes · 4
  1. F1The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $3.5100 to $3.6000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  2. F2Includes 542,784 restricted stock units.
  3. F3The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
  4. F4The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Open on SEC EDGAR
John T. TreaceDirector · Chief Executive Officer · 10% owner
4
Filed May 28, 2026Period of report May 26, 20260001193125-26-245341
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 28, 2026
Common StockF5F261,202$3.0199$184.82K7,273,833Direct
PurchaseMay 27, 2026
Common StockF4F249,810$2.8747$143.19K7,212,631Direct
PurchaseMay 26, 2026
Common StockF1F24,508$2.7897$12.58K7,162,821Direct
Filing footnotes · 6
  1. F1The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.7600 to $2.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  2. F2Includes 542,784 restricted stock units.
  3. F3The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
  4. F4The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.7976 to $2.9400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  5. F5The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.8233 to $3.1150 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  6. F6The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Open on SEC EDGAR
John T. TreaceDirector · Chief Executive Officer · 10% owner
4
Filed May 14, 2026Period of report May 12, 20260001193125-26-224391
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMay 14, 2026
Common StockF4F261,750$2.6153$161.49K7,158,313Direct
PurchaseMay 13, 2026
Common StockF3F249,013$2.4592$120.53K7,096,563Direct
PurchaseMay 12, 2026
Common StockF1F243,000$2.1739$93.48K7,047,550Direct
Filing footnotes · 6
  1. F1The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $1.9100 to $2.2800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  2. F2Includes 542,784 restricted stock units
  3. F3The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.3850 to $2.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  4. F4The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $2.4950 to $2.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
  5. F5The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
  6. F6The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.